Elora Therapeutics is developing the first enzyme therapeutic to degrade and safely remove microplastics from the human body. Using engineered enzymes, we target synthetic polymers that accumulate in blood and tissues, compounds our human biology cannot naturally eliminate. These microplastics are linked to chronic inflammation, metabolic disease, and hormone disruption — we aim to help improve these indications by targeting a source of the symptoms. Our mission is to restore internal balance in an increasingly synthetic world. Backed by sound science and academic partnerships, we’re laying the groundwork for a new category of biologic therapeutics focused on systemic resilience and long-term health.
Company Details
- Employees
- 2
- Founded
- -
- Address
- Austin, Texas, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://eloratherapeutics.com
- Keywords
- Holbrook.
- HQ
- Austin, Texas
Elora Therapeutics Questions
Elora Therapeutics's website is http://eloratherapeutics.com
Elora Therapeutics's LinkedIn profile is https://www.linkedin.com/company/elora-therapeutics
Elora Therapeutics has
2 employees.
View email and phone details for 2
employees at Elora Therapeutics.
Elora Therapeutics's industry is
Biotechnology Research
Elora Therapeutics's top competitors are
Ignite Biomedical,
J,
Long Island Analytical Laboratories, Inc.,
Mirador Software Group,
Accuone Hiring Solutions, Llc,
Bellsant,
J,
Accuon Labs Inc,
Brenig Therapeutics,
Smartweave Inc.
Elora Therapeutics's categories are Biotechnology Research
Elora Therapeutics's founding year is 2025
